Good morning! Prolynx shares rat data it says could support obesity medicines dosed once every three months. Also today: a surgeon on more temple filler after GLP-1 weight loss, a Crewe man charged over Mounjaro at a drug distributor, and two-year weight changes after five next steps in 20,486 people. Listen to me read them above, or read the key details below.
Daily Roundup:
Prolynx shares rat data it says could support obesity medicines dosed once every three months (The Manila Times)
A surgeon reports more temple filler after GLP-1 weight loss (Daily Mail)
A Crewe man faces theft charges over Mounjaro at the drug distributor where he worked (Warrington Guardian)
Cleveland Clinic researchers compare weight after five different next steps on GLP-1 shots (Medscape)
Prolynx shares rat data it says could support obesity medicines dosed once every three months
Key Details:
The Emeryville, California, biotech presented three posters at ObesityWeek 2026 on Saturday, November 14.
In rats with diet-induced obesity, a single dose of an amylin drug kept up weight loss for 12 weeks.
A GLP-1 and GIP drug reached a half-life of more than one month.
Chief Executive Chris Boulton said: "... weekly injections and dosing-related side effects remain real barriers to long-term treatment."
Source: The Manila Times
A surgeon reports more temple filler after GLP-1 weight loss
Key Details:
Melissa Rivers, 58, told the New York Post she lost 25 pounds on Mounjaro in six months, then developed temporal hollowing, a sunken look at the temples.
She had collagen-stimulating filler injections and a radiofrequency skin-tightening treatment.
Facial plastic surgeon Dr. Lesley Rabach told the Daily Mail: "... there's been a significant uptick in both temple filler as well as temple fat transfer in patients who've had significant weight loss from GLP-1s."
Filler that lasts about a year can cost 5,000 to 7,000 dollars, she said, and fat transfers run 15,000 to 18,000.
Source: Daily Mail
A Crewe man faces theft charges over Mounjaro at the drug distributor where he worked
Key Details:
Jamie Taylor, 32, appeared at Warrington Magistrates' Court on Wednesday.
The charges are theft by an employee and handling stolen goods, between January 26 and March 13.
It is alleged he took the drug while working at AAH Pharmaceuticals, a health care distributor in Winwick Quay.
He has not entered a plea yet, remains on conditional bail, and is due back in court on November 24.
Source: Warrington Guardian
Cleveland Clinic researchers compare weight after five different next steps on GLP-1 shots
Key Details:
The study used health records from 20,486 people at Cleveland Clinic centers in Ohio and Florida who started on semaglutide or tirzepatide, and it was presented at ObesityWeek.
After two years, weight was down 10.9 percent for people who stayed on their first medicine, 16 percent for those who switched between the two drugs, and 8.2 percent for those who moved to another obesity medicine.
Weight was down 28.2 percent after bariatric surgery and 4 percent for people who stopped their medicine.
The authors note the study was observational and say prospective real-world studies are needed to confirm the findings.
Source: Medscape
Learn More
Join the free GLP-1 community Cozy Butter: cozybutter.com
Listen to GLP-1 Radio, GLP-1 shows all day: glp1radio.com
Every GLP-1 Studio Daily episode: GLP-1 Studio Daily
About Amanda Bonello: amandabonello.com
This is a reader-supported publication, thank you so much for your support.
💖












